Intradermal Hepatitis-B-vaccination in non-responders after topical application of imiquimod 5%.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2010
At a glance
- Drugs Imiquimod (Primary) ; Hepatitis B vaccine recombinant (HBvaxPro)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 04 Jun 2010 Results published in Vaccine.
- 04 Jun 2010 Status changed from recruiting to active, no longer recruiting.
- 23 Sep 2009 Last checked against Netherlands Trial Register